Search
Menu
Home
HTB
IDWeek 2024
IDWeek 2024
Detailed results from PALM007 study: no clinical impact of tecovirimat against mpox clade 1
6 January 2025. Related:
mpox
.
HTB RSS
Early access
Clinical studies of two once-weekly pipeline compounds put on hold
3 July 2025
Kigala Call to Action: sign-on for IAS 2025 conference
1 July 2025
HIV organisations support trans and non-binary communities against the unworkable EHRC guidelines
30 June 2025
Long-acting injectable PrEP approved in the US: priced at $28,000 a year
28 June 2025
All early access reports
Current issues
July 2025
June 2025
May 2025
Back issues
Special report
Why the new HIV PrEP guidelines from the UK are so exciting
2 July 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate
